Dentin extracellular Matrix
Molecules implanted into exposed Pulps Generate reparative Dentin: a Novel strategy in regenerative Dentistry F or years, dental surgeons have used calcium hydroxide as the 'gold standard' therapy for direct pulp-capping. Depending on the degree of bacterial contamination, pulp inflammation, and tissue degradation, the results vary.
The effects of pulp-capping with Ca(OH) 2 are associated with a slight inflammation at early stages (Schröder, 1985) . Proinflammatory cytokines and chemokines seem to recruit immune cells and progenitors involved in the healing mechanisms. The cascade of events initiated by this procedure includes cell commitment, proliferation, and migration, and, finally, the terminal differentiation of odonto/osteoprogenitors (Fitzgerald et al., 1990) . Direct pulp-capping with calcium hydroxide forms a reparative "dentin-like" bridge, which includes tunnels containing pulp remnants and cell lacunae. Pulp healing occurs beneath this layer of regenerated osteodentin structure. Compared with orthodentin, this permeable barrier is less resistant to bacterial re-contamination and secondary caries, and the frequent outcome of pulp capping is complete removal of the pulp by endodontic treatment. The results of pulp-capping studies have variable reports of success. After 5 years, about 45% of the pulp caps fail, and this percentage may rise to 80% after 10 years. The occurrence of such failures leads to the search for alternative possibilities. Cell and molecular biologists involved in tissue engineering are studying promising new approaches and materials.
In the 1990s, studies of the potential for biological molecules to form reparative dentin were initiated. Researchers have evaluated the potential of growth factors to stimulate pulp repair. The results obtained with growth factors were disappointing, because osteodentin was produced extensively, with tunnels and lacunae. The lack of formation of a solid permeability barrier led to the same defects as the Ca(OH) 2 capping.
Following from these initial studies, there are currently three different approaches for triggering pulp healing. The first of these is to use mineral calcium phosphates to enhance the formation of a reparative dentinal bridge. A second approach is to use bioactive extracellular matrix (ECM) molecules that may be implicated directly in pulp mineralization or act indirectly on the commitment and differentiation of pulp progenitors. Finally, the uses of stem cells identified within the dental pulp can also be envisioned. Stem cells have the ability to differentiate into odontoblast/osteoblast-like lineages and are the most recent addition to the treatment arsenal.
BoNe siALoProTeiN
International conferences provide special opportunities to meet colleagues and develop new projects. During a midnight session at the 1997 "Tooth Morphogenesis and Development" conference in Göteborg, I was sitting with Erdjan Salih, who was working in Mel Glimcher's lab in Boston, and learned more of their research. This group used molecules extracted from bone to promote the healing of defects in calvaria. After bone matrix molecules were implanted, progenitors were recruited, differentiated, and formed a cartilage structure, which was then further replaced by bone, following the classic steps of endochondral bone formation (Wang et al., 1998) . Bone sialoprotein (BSP), rather than osteopontin (OPN), promoted bone healing. BSP also promotes direct nucleation of hydroxyapatite (HAp), its glutamic-acid-rich sequences representing a general site for growth-modulating interactions between the protein and the crystal (Hunter and Goldberg, 1993) . BSP enhances the fibrillation of collagen fibrils (Fujisawa and Kuboki, 1992) . These properties were the basis for the use of this molecule as a pulpcapping agent. We decided to collaborate. Soon after, the purified BSP was implanted into the pulps of rat molars.
For these studies of BSP, we used our recently developed rat model system derived from a previously published method (Ohshima, 1990) . Half-moon cavities were prepared in the mesial aspect of the first maxillary molar. Piercing the residual dentin with a steel probe allowed for a controlled pulp exposure, and collagen pellets loaded with BSP were implanted into the pulp. The pulp was protected from bacteria when the cavity was filled with a glass-ionomer cement (Decup et al., 2000) .
After 7 days, slight inflammation was observed in the mesial part of the pulp. After 14 days, inflammation was largely resolved. An initial thin layer of reparative dentin was seen, showing that the repair process had begun. At day 30, the pulp exposure was totally filled with a homogeneous atubular dentin-like structure, extensively occluding the mesial part of the coronal pulp chamber. This was the first evidence that a bioactive ECM molecule could be used as a capping agent more efficiently than Ca(OH) 2 .
During the past several years, the interest in dentin and bone ECM molecules has increased for the following three reasons.
First, the bulk of ECM molecules are structural proteins that form a three-dimensional scaffold of bone and dentin structures.
Second, more recently, some ECM molecules have been characterized as matricellular proteins. They participate in the pericellular environment. They interact with structural macromolecules and mediate interactions between cells and the ECM. Matricellular proteins modulate the signaling events occurring between the ECM and cell-surface receptors. They are implicated in cell adhesion, migration, proliferation, survival, and differentiation. BSP and OPN belong to this group of proteins (Bornstein and Sage, 2002) . However, classification of molecules such as OPN is difficult, since they share structural, matricellular, and inflammatory functions.
Third, after specific interaction with membrane receptors and internalization into the cell, ECM molecules play dynamic role(s) as signaling molecules. In this context, small spliced forms of the molecules or peptidic domains resulting from the cleavage or partial degradation of ECM molecules are probably more adapted to fit this role. If they are recognized by specific surface receptors, they are translocated to the nucleus, and may activate the cascade of signals (Veis, 2003) . Because the 3 aspects combine, ECM molecules display multifaceted properties that contribute to pulp repair.
iMPLANTATioN oF AMeLoGeNiNs iNTo THe PULP: A±4
After BSP, we decided to explore more systematically the bioactive properties of ECM molecules as pulp-capping agents. The Biora Company had decided to sponsor a boat trip along the Norwegian coast, an informal 'floating conference' between Tromsø and Bergen. Together with 20 scientists, every day during this working holiday, we had heated discussions and quarrels, with short interruptions due to the beauty of a fjord, a mountain, trolls and fairies, whales, or feeding events. During that trip, Art Veis told me more about the spliced gene product discovered under his leadership.
Originally, the name of its protein was the Chondrocyte Inducing Agent; therefore, the acronym was CIA. This was a little embarrassing, since customs officials became nervous, finding a snow-white powder sent from Chicago to Paris in a translucent plastic bag. Veis and his collaborators discovered two biologically active forms of the molecule and turned the name into A+4 and A-4-less suspicious and easier for crossing borders. They identified 2 specific cDNAs in the rat incisor odontoblast/pulp library, the first resulting from expression of amelogenin gene exons 2, 3, 4, 5, 6d, and 7 [A+4, 73aa, 8.1 kDa] , and the second from exons 2, 3, 5, 6d, and 7, the expression of exon 4 being omitted [A-4, 59aa, 6.9 kDa, that exclude the 14-amino-acid sequence encoded by exon 4, also referred to as LRAP].
In culture, A+4 stimulated Sox9 expression, whereas A-4 stimulated Runx2/Cbfa1 mRNA expression (Veis et al., 2000) . Lamp-1 has recently been described as a membrane receptor for A-4, involved in the internalization of the molecule.
For years, there had been general agreement that amelogenins were exclusively synthesized by ameloblasts. The different molecular weights reported for the major proteins of developing enamel are known to result from alternative splicing(s) or from the immediate degradation of amelogenins. Undegraded spliced forms of amelogenins are recognized in rat incisors and porcine odontoblasts, as well as in pulp cells (Veis et al., 2000; Oida et al., 2002) . Therefore, amelogenin cannot be considered exclusively as a structural enamel protein, and many data have now converged to point to the signaling properties of A±4 (Veis, 2003) .
After the implantation of agarose beads loaded with A±4 for 3-7 days, a burst of cell proliferation could be observed, as shown by Proliferation Cell Nuclear Antigen (PCNA) immunolabeling. Detectable from day 3, the labeling increased at day 7 for A-4, while it decreased for A+4. The 2 molecules displayed obvious differences, likely related to the presence or absence of the 14 amino acids expressed by exon 4. This early step occurs concomitantly with a slight inflammatory process. However, we have not determined whether the proliferating cells are stem cells, or are derived from structural fibroblasts (or pulpoblasts, according to Baume, 1980) or inflammatory cells. The link between cell proliferation and cell commitment remains to be established.
After 7-15 days, PCNA-positive cells are seen near the A±4-loaded beads, never attached to the surfaces of the beads, but at a short distance. At day 30, labeling is reduced in the coronal pulp. In the root, at day 15, PCNA-positive cells are present only beneath the sub-odontoblastic cell layer, and never in the central part. Later, no labeling was detectable at day 30 in the radicular pulp.
In the coronal pulp, at day 15, cell proliferation is accompanied by the migration of cells moving from the vascularized central part toward the periphery of the pulp (Fitzgerald et al., 1990) . This suggests that the dividing pulp cells migrate axially in the root, in the direction of the crown, and centrifugally from the center of the pulp chamber toward the outer part of the crown (Six et al., 2004) . Our in vitro studies did not establish any evidence for chemotactic properties of A±4. The mechanisms involved in the migration process are not known. If motility is a prerequisite, this excludes structural fibroblasts as candidates, since they are bound together by desmosome-like and gap junctions, unless a phenotypic interconver sion also modifies the structure of the junctional complexes.
Inflammatory cytokines or molecules released by stem cells may be implicated in the commitment of cells that migrate toward the wounded area. After the recruitment of a sufficient number of progenitors, a limited number of cell divisions will allow the pulp cells to reach the required cell density. Clearly, commitment and migration are combined during the early events of pulp repair. The cells that gather near the implanted beads become progenitors.
To reveal early differentiation of progenitor cells, we used RP59, a protein produced by hematopoietic precursors, primitive mesenchymal cells, and osteoblast and odontoblast progenitors (Krüger et al., 2002) . Positive labeling is indicative of early differentiation stages. RP59 labeling in pulpal cells increases gradually between 1 and 3 days for A-4 and is stable up to day 7, whereas after a peak at day 3, labeling is decreasing at day 7 for A+4. Analysis of these data indicates that early differentiation starts immediately after migration and proliferation. In the implanted pulp, RP59-positive cells are less numerous than PCNA-positive colonies, but they share the same pulp territories. Hence, this suggests that differentiating cells are issued from the proliferating/migra ting cells.
Around the beads, in close contact with the surface, the first ring of cells is positively labeled for OPN, especially at day 15. Although OPN is actually a structural and matricellular ECM protein, it is also implicated in inflammatory processes. Therefore, the positive labeling detected during the first days following implantation may be due to a combination of events related to the inflammation process induced by the surgical trauma and bead implantation, on the one hand, and to the early differentiation of osteoblast-like progenitors, on the other. Although agarose beads display bioactive intrinsic properties, the beads are foreign bodies, as revealed in pulps implanted with unloaded beads. As part of this inflammatory reaction, OPN-positive cells appear in the inflamed pulp (Jegat et al., 2007) . By contrast, the inflammatory process is resolved at day 15, and OPN labeling is mostly restricted to cells located at the surfaces of the beads. This distribution is probably related to the terminal differentiation of progenitors into osteoblast-like cells.
No labeling is detected at early stages of differentiation for dentin sialoprotein (DSP). For a long time, DSP was considered to be specific to the odontoblast phenotype. It is now recognized that it is not an exclusive marker, the molecule being also expressed in bone, in the mouse inner ear, and by pre-ameloblasts at very early stages of tooth formation (Qin et al., 2002) . However, the molecule is strongly expressed by odontoblasts and therefore is a good indicator of the phenotype. At day 15, DSP-positive cells are present in a limited area near the pulp exposure. This is the place where a true dentinal bridge of reparative dentin is formed when A+4 is used. Compared with Ca(OH) 2 , the homogeneity of this dentinal bridge predicts an advantage in the use of A+4. When A-4 is used, cells produce diffuse mineralization, occluding the mesial coronal pulp. At day 15, the lumen of the root canal is reduced and is totally closed at day 30 (Six et al., 2004) . Therefore, A+4 differs from A-4 at all the stages of reparative dentin formation examined. No further modifications were recorded between 30 and 90 days after implantation, suggesting that the reaction is switched off, and does not expand toward periodontal tissues. 
DeNToNiN, A PePTiDe oF MePe
Thus far, the use of A±4 and BSP as biomolecules to promote dentin regeneration and pulp repair has led to promising results ( Fig.) . The list of dentin ECM components is far longer, and other proteins as full-length molecules or as peptides formed after fragmentation into specific domains may provide interesting results. At that point, we need to know if each ECM molecule implantation leads to reparative dentin formation and pulp healing, or if only a few molecules are bioactive. To answer this question, we have initiated a rewarding collaboration with Pam DenBesten, and we have shown that Dentonin, a peptide of Matrix Extracellular PhosphoglycoprotEin (MEPE), a member of the SIBLING family, stimulates the commitment, proliferation, and differentiation of osteoblast-like progenitors. However, in contrast to BSP and A±4, the reaction is stopped before the final formation of a dense layer of reparative dentin (Six et al., 2007) .
This demonstrates that each molecule or bioactive domain displays its own specificity, which has to be taken into account. To develop the potential of these biomolecules further, it seems crucial to understand the mechanisms underlining these processes of dentin regeneration and pulp repair.
Similar results may be obtained by the implantation of stem cells, currently under study in our group. As recombinant molecules produced by bacteria, ECM proteins or peptides are easier to obtain than fishing for progenitor cells, and immunologic reactions due to species differences are minimized. Together, they provide a simplified approach that paves the way for regenerative dentistry.
